E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma
Clinical trial NCT00413192 · COMPLETED
Trial details
- NCT number
- NCT00413192
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2012-06-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.